Marianna Adamo

Interventional cardiologist / Cardiologist
University of Brescia - Brescia, Italy

Latest contributions

Advancing the management of tricuspid valve disease: diagnosis, imaging, and intervention

01 Feb 2025 – From PCR Imaging Valves Madrid 2025

This session explores tricuspid valve disease, focusing on the determinants and severity of tricuspid regurgitation, right heart assessment, and available treatment options. Through case studies and expert discussions, learn about imaging techniques, the heart team approach, and best practices for selecting patients for transcatheter tricuspid valve...

Advancing the management of tricuspid valve disease

Mastering mitral valve disease: diagnosis, management, and intervention

31 Jan 2025 – From PCR Imaging Valves Madrid 2025

Dive into this comprehensive session on mitral valve disease, covering key aspects of diagnosis, classification, assessment, management, and patient selection for transcatheter intervention. Gain in-depth knowledge through real-world case studies and multidisciplinary team discussions, equipping you with essential skills to optimize patient care.

Mastering mitral valve disease: diagnosis, management, and intervention

How to implement a successful structural intervention programme

26 Nov 2024 – From PCR London Valves 2024

Embark on a journey to learn how to implement a successful structural intervention program. Discover the essential requirements for building transcatheter valve intervention capabilities, including the necessary equipment, personnel, and training programs. Gain insights on establishing aortic, mitral, and tricuspid intervention programs, as well as creating...

How to implement a successful structural intervention programme

Multivalve disease: defining pathways for optimal assessment and treatment in the absence of good clinical evidence

26 Nov 2024 – From PCR London Valves 2024

Curious about managing multivalve disease in the absence of robust clinical evidence? This video is a must-watch!

You'll explore the latest strategies for assessing and treating this condition (including advanced multimodality investigations like echocardiography, magnetic resonance and cardiac catheterisation), and learn how to evaluate cardiopulmonary interactions and...

Multivalve disease: defining pathways for optimal assessment and treatment in the absence of good clinical evidence

Clinical management before and after transcatheter tricuspid valve intervention

25 Nov 2024 – From PCR London Valves 2024

Looking to refine your approach to managing patients undergoing transcatheter tricuspid valve intervention? This video is for you!

You'll learn how to optimize patient preparation, master pathways for effective medical management before, during and after the procedure, and tackle specific post-procedural complications such as thrombosis, conduction disturbances...

Clinical management before and after transcatheter tricuspid valve intervention

RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation

25 Nov 2024 – From PCR London Valves 2024

Join this compelling session focused on the transcatheter treatment of mitral and tricuspid regurgitation. Explore detailed case discussions, including a mitral regurgitation case, a challenging MitraClip procedure, and a severe tricuspid regurgitation case. Discover key takeaways from the RESHAPE, MATTERHORN, and Tri.FR trials, and learn how...

RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation

TAVI and coronary artery disease

24 Nov 2024 – From PCR London Valves 2024

How does coronary artery disease shape outcomes in TAVI patients, and when should revascularization come into play? This video explores these critical questions, offering a deep dive into the latest evidence and strategies for managing combined aortic stenosis and coronary artery disease.

From understanding revascularization timing to...

TAVI and coronary artery disease

Transcatheter solutions for combined valve disease

17 May 2024 – From EuroPCR 2024

This session delves into the transcatheter management of patients with combined valve disease, including cases of concomitant aortic stenosis and mitral regurgitation, failed bioprostheses in both the aortic and mitral valves, and severe aortic regurgitation after previous valve-sparing root replacement. The session features case presentations and...

Transcatheter solutions for combined valve disease

To repair or to replace the mitral valve: that is the question

16 May 2024 – From EuroPCR 2024

This session provides a comprehensive understanding of both transcatheter edge-to-edge repair (TEER) and transcatheter mitral valve replacement (TMVR) techniques, including their respective advantages, suitability criteria, and clinical outcomes. The session features insights from a surgeon's perspective on the considerations and techniques involved in mitral valve repair...

To repair or to replace the mitral valve: that is the question

Patient management before, during, and after transcatheter tricuspid valve replacement

16 May 2024 – From EuroPCR 2024

In this session, explore key aspects of transcatheter tricuspid valve replacement, including the role of right ventricular function, pre-procedural hemodynamics, and factors that contribute to procedural success or failure, and gain insights into patient selection criteria, essential imaging techniques, and best practices for post-procedural care, both...

Patient management before, during, and after transcatheter tricuspid valve replacement

Mitral and tricuspid hotline

16 May 2024 – From EuroPCR 2024

This session provides updates on the latest developments in transcatheter mitral and tricuspid valve interventions. Key topics include one-year outcomes of the MiCLASP study on transcatheter mitral repair, the impact of residual mitral and tricuspid regurgitation after transcatheter repair, and the early feasibility of the AltaValve...

Mitral and tricuspid hotline

How to achieve optimal results in tricuspid valve interventions?

15 May 2024 – From EuroPCR 2024

How to achieve optimal results in tricuspid valve interventions?

Transcatheter tricuspid valve replacement - LIVE case

15 May 2024 – From EuroPCR 2024

An 82-year-old male with a history of STEMI in 2013, stroke in 2018, cancer, and permanent AF, presented with acute heart failure with predominant right-side failure. Severe tricuspid regurgitation was identified.
The operators implanted an Evoque valve percutaneously under TEE guidance and general anaesthesia via the venous...

Transcatheter tricuspid valve replacement

Tricuspid valve intervention in complex scenarios - Patient and procedural optimisation

20 Nov 2023 – From PCR London Valves 2023

Watch this session to enhance your knowledge on optimizing patients throughout the entire transcatheter tricuspid valve intervention process— from pre-procedure preparation to post-procedural care. Learn effective strategies for managing immediate and early complications, refine post-procedural treatment plans, and gain insights into future strategies aimed at further...

Tricuspid valve intervention in complex scenarios - Patient and procedural optimisation

Tricuspid valve intervention in complex scenarios - Tackling tricuspid regurgitation using a multidisciplinary approach

20 Nov 2023 – From PCR London Valves 2023

This session explores the diverse phenotypes of tricuspid regurgitation patients, emphasizing the clinical implications and advocating for a multidisciplinary approach to assessment and treatment. It covers TR clinical courses, investigation pathways, and case scenarios, including atrial fibrillation, heart failure (preserved and reduced ejection fraction), pulmonary hypertension,...

Tricuspid valve intervention in complex scenarios - Tackling tricuspid regurgitation using a multidisciplinary approach

Controversies in atrioventricular valves - The Heart Team ring, Vol II

19 Nov 2023 – From PCR London Valves 2023

This session offers an opportunity to engage in a real case discussion led by an advanced Heart Team. Participate in discussions on controversial decision-making scenarios and stay informed about the latest clinical evidence related to MitraClip, Tendyne, and TriClip therapies.

Controversies in atrioventricular valves

Key questions in mitral valve intervention - Transcatheter edge-to-edge repair (Part 1) - what do I need to know to do the procedure safely?

19 Nov 2023 – From PCR London Valves 2023

Analyze in depth the case of a 64-year-old female patient with ischaemic cardiomyopathy with LVEF 40 % and severe ventricular mitral regurgitation, who previously had NSTE-ACS treated with LAD and circumflex PCI, and who presented with recent worsening heart failure and persistent NYHA class II-III, and...

Key questions in mitral TEER - what do I need to know to do the procedure safely?

Knocking mitral regurgitation down to improve outcomes: earlier is better, but better late than never! (Episode 2: the left side)

18 May 2023 – From EuroPCR 2023

Help optimize your patients' prognosis by attending this session! You'll learn how proper patient selection and timely interventions lead to lasting results and how to use the latest real-world registry data to gain insight into the safety and effectiveness of M TEER.

Optimal management of right ventricular pacing leads in patients with tricuspid regurgitation

28 Nov 2022 – From PCR London Valves 2022

Consult these presentations to learn more about the consequences of right ventricular pacing lead implantation on tricuspid valve function, the diagnosis and imaging assessment of lead-induced tricuspid regurgitation and the possible treatment options for patients with right ventricular pacing leads and significant tricuspid regurgitation.

Optimal management of right ventricular pacing leads in patients with tricuspid regurgitation

Tricuspid valve interventions in heart failure patients - Treatment optimisation and pre-procedural work-up

27 Nov 2022 – From PCR London Valves 2022

Consult these presentations to learn more about tricuspid valve intervention in heart failure patients, to discover which patients are suitable candidates for this procedure and to appreciate the importance of imaging, haemodynamic assessment, optimised medical and heart rhythm treatment prior to this intervention.

Tricuspid valve interventions in heart failure patients - Treatment optimisation and pre-procedural work-up

Mitral replacement: expanding patient options, even mitral annular calcification!

18 May 2022 – From EUROPCR 2022

The objectives of this session from EuroPCR 2022 are to provide the best pathway for mitral regurgitation management, to learn about early commercial TMVR experience and to discover treatment options for mitral annular calcification patients.

Advances in transcatheter mitral and tricuspid repair

18 Nov 2019 – From PCR London Valves 2019

Consult this session to learn about the recent advances in transcatheter mitral and tricuspid repair and their impact on your clinical practice, thanks to various registries and studies, such as EREMMI, GRASP-IT, LVEF, CLASP, and more!

Advances in transcatheter mitral and tricuspid repair